Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinical Chemistry and Laboratory Medicine
|
November 19, 2002
Overcoming multidrug resistance in taxane chemotherapy
Raphaël Geney, loana Maria Ungureanu, Dansu Li, et al.
IUBMB Life
|
July 18, 2002
Medicinal chemistry and chemical biology of new generation taxane antitumor agents
Iwao Ojima, Raphael Geney, Ioana Maria Ungureanu, et al.
Journal of Lipid Research
|
June 4, 2004
Benzophenone-containing cholesterol surrogates: synthesis and biological evaluation
Thomas A Spencer, Pingzhen Wang, Dansu Li, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence
Chia-Ping Huang Yang, Pascal Verdier-Pinard, Fang Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2017
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors
Ling Tong, Seong Heon Kim, Kristin Rosner, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 5, 2011
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors
Chaoyang Dai, Dansu Li, Janeta Popovici-Muller, et al.
Cell
|
August 28, 2018
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Waleed Minzel, Avanthika Venkatachalam, Avner Fink, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2010
Discovery and SAR of hydantoin TACE inhibitors
Wensheng Yu, Zhuyan Guo, Peter Orth, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2014
Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Anthony J Roecker, Thomas S Reger, M Christa Mattern, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinical Chemistry and Laboratory Medicine
|
November 19, 2002
Overcoming multidrug resistance in taxane chemotherapy
Raphaël Geney, loana Maria Ungureanu, Dansu Li, et al.
IUBMB Life
|
July 18, 2002
Medicinal chemistry and chemical biology of new generation taxane antitumor agents
Iwao Ojima, Raphael Geney, Ioana Maria Ungureanu, et al.
Journal of Lipid Research
|
June 4, 2004
Benzophenone-containing cholesterol surrogates: synthesis and biological evaluation
Thomas A Spencer, Pingzhen Wang, Dansu Li, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence
Chia-Ping Huang Yang, Pascal Verdier-Pinard, Fang Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 1, 2017
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors
Ling Tong, Seong Heon Kim, Kristin Rosner, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 5, 2011
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors
Chaoyang Dai, Dansu Li, Janeta Popovici-Muller, et al.
Cell
|
August 28, 2018
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Waleed Minzel, Avanthika Venkatachalam, Avner Fink, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 23, 2010
Discovery and SAR of hydantoin TACE inhibitors
Wensheng Yu, Zhuyan Guo, Peter Orth, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 25, 2014
Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Anthony J Roecker, Thomas S Reger, M Christa Mattern, et al.
Page
of 2